CLO26-098: Factors Associated With Tumor Progression in HR+/HER2- Metastatic Breast Cancer Treated With CDK4/6 Inhibitors: A Multi-Center Real-World Experience.

View at publisher Summarise with VIRAT
Authors: Ahmad Alhalabi, Theresa Abdo, Hong Liang, Zeina A. Nahleh
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Advanced Breast Cancer Therapies Breast Cancer Treatment Studies PARP inhibition in cancer therapy

Publication details

Journal / source
Journal of the National Comprehensive Cancer Network
Volume
24
Issue
3.5
Publication date
27 March 2026
Language
EN